Institutional Ownership
Chemomab Therapeutics Ltd
CUSIP 16385C203SPONSORED ADSCMMBQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
4.6%
Max % of class reported
Institutional Holders
15
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Peter Thiel | 13G/A | 4.6% | 22.63M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Adar1 Capital Management, LLC | 80.0K | $125.6K |
| 2 | Citadel Advisors LLC | 64.2K | $100.8K |
| 3 | Kestra Private Wealth Services, LLC | 61.7K | $96.9K |
| 4 | Ikarian Capital, LLC | 51.8K | $81.3K |
| 5 | Xtx Topco Ltd | 18.6K | $29.2K |
| 6 | Rhumbline Advisers | 18.4K | $28.8K |
| 7 | Smartharvest Portfolios, LLC | 14.6K | $22.9K |
| 8 | Susquehanna International Group, LLP | 13.5K | $21.2K |
| 9 | Bnp Paribas Financial Markets | 8.4K | $13.2K |
| 10 | Philadelphia Investment Partners, LLC | 8.2K | $12.9K |